Intelligent Bio Solutions Inc. (INBS) Cash from Investing Activities (2022 - 2025)

Intelligent Bio Solutions' Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$14385.0 for Q1 2025.

• In Q1 2025, Cash from Investing Activities fell 663.9% year-over-year to -$14385.0; the TTM figure through Mar 2025 stood at -$19781.0 (up 90.87% YoY), while the FY2023 annual figure was -$694142.0, up 21.14% from the prior year.
• Cash from Investing Activities for Q1 2025 stood at -$14385.0, down from $2551.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $173803.0 in Q1 2023, with the low at -$703013.0 in Q2 2022.
• The 4-year median for Cash from Investing Activities is -$181750.0 (2023), against an average of -$201284.1.
• The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities jumped 74.15% in 2023, then tumbled 663.9% in 2025.
• Intelligent Bio Solutions' Cash from Investing Activities stood at -$211304.0 in 2022, then grew by 13.99% to -$181750.0 in 2023, then soared by 101.4% to $2551.0 in 2024, then sank by 663.9% to -$14385.0 in 2025.
• Business Quant data shows INBS's Cash from Investing Activities at -$14385.0 in Q1 2025, $2551.0 in Q1 2024, and -$181750.0 in Q2 2023.